Read more

June 12, 2021
1 min read
Save

Zimmer Biomet announces two new appointments to execute leadership team

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Zimmer Biomet Holdings Inc. has appointed Wilfred van Zuilen as president of the Europe, Middle East and Africa division of the company, and Nitin Goyal, MD, as chief science, technology and innovation officer, according to a press release.

As President of Europe, Middle East and Africa (EMEA), van Zuilen will be responsible for marketing, sales and distribution of Zimmer Biomet’s line of products, services and solutions in those regions, according to the release.

“We’re thrilled to have Wilfred join the Zimmer Biomet team to help advance our mission and drive forward our business in the EMEA region,” Ivan Tornos, chief operating officer of Zimmer Biomet, said in the release. “His experience in med tech, coupled with his deep knowledge of the EMEA region’s business needs, make him the ideal candidate for this role.”

In the newly created role of chief science, technology and innovation officer, Goyal will oversee development of advanced research and innovation platforms at the company.

“Dr. Goyal joins the Zimmer Biomet team at a time when we’re advancing our portfolio of seamlessly connected digital health and robotic technologies that are designed to deliver data-powered clinical insights throughout the surgical journey,” Tornos said. “His clinical experience and expertise in the digital transformation of musculoskeletal care make up the perfect skillset to help drive forward our business at this vital time in the company’s transformation.”

“It is an exciting time at Zimmer Biomet as we continue to build out our executive team to ensure we have the proven, strategic leadership in place to guide us through the third phase of our business transformation,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. “As an organization, we remain focused on developing our people, placing the right team members in the right roles and providing the tools and support needed to execute and drive our performance,” Hanson added.